Placentas, usually discarded after childbirth, are a rich source of stem cells, collagen, and cytokines, giving them significant potential for alleviating pain, reducing inflammation, and promoting the healing of chronic wounds. In the U.S., there are approximately 4 million births each year, yet only a small fraction - less than 1% - of placental blood and tissue is preserved. However, there is growing awareness of the vast potential of placental tissue.
The stock we are bringing to your attention today is that of MiMedx Group Inc. (MDXG), a pioneer in placental biologics providing a portfolio of products for applications in wound care, burn, and surgical sectors of healthcare.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.